Liquid Biopsy
Resources
COVID-19
SAFER™
DeepMARK™
News
Company
Join Us
Contact
Singapore Studying the Feasibility, Reliability of Saliva Tests for Covid-19
In the News
June 25, 2020
Read full article
here
.
Recent Posts
Lucence Receives CLIA Certification for US Laboratory, Expands Access to Amplicon-Based Liquid Biopsy Tests
December 10, 2020
Lucence Launches DeepMARK™ for Profiling of SARS-CoV-2 Subgenomic RNA
October 7, 2020
Lucence Launches SAFER™ Technology Suite for Accurate COVID-19 Detection Using Naso-Oropharyngeal Saliva
August 18, 2020
Lucence and Akribis Collaborate on COVID-19 Saliva Processing Automated Platform to Enable Mass Testing
July 2, 2020
Singapore Studying the Feasibility, Reliability of Saliva Tests for Covid-19
June 25, 2020
Please wait while you are redirected to the right page...
Please share your location to continue